Pfizer Inc. (PFE) reports 24 holdings totaling $437.45M on 13F

Rhea-AI Filing Summary

Pfizer Inc. filed a Form 13F reporting holdings: 24 instrument entries with a total value of $437,450,705. The report was signed on 11-13-2025. This filing lists institutional equity positions held by the manager as of the reporting period and summarizes aggregate value and count of entries.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 09-30-2025

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	Pfizer Inc
Address:	66 Hudson Boulevard East
	New York, NY 10001-2192
Form 13F File Number:	028-25239
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Madelyn D. Purcell
Title:		Assistant Secretary
Phone:		212-733-4293
Signature, Place, and Date of Signing:
/s/ Madelyn D. Purcell			New York, NY	11-13-2025
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		0
	Form 13F Information Table Entry Total:		24
	Form 13F Information Table Value Total:		437,450,705
			(round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

NONE

FAQ

What does Pfizer's (PFE) Form 13F report show?

It shows Pfizer reported 24 holdings valued at $437,450,705. The Form 13F is a quarterly disclosure of institutional equity positions filed by the manager and signed on 11-13-2025, summarizing count and aggregate market value.

When was the Form 13F signed for Pfizer (PFE)?

The Form 13F was signed on 11-13-2025. The signature block names Madelyn D. Purcell, Assistant Secretary, certifying the report and providing a phone contact on the cover page.

How many holdings did Pfizer list on this 13F filing?

The filing lists 24 information-table entries. The Form 13F summary page shows the number of reported holdings entries and the aggregate market value rounded to the nearest dollar.

What is the total value reported on Pfizer's 13F?

The aggregate Form 13F value is $437,450,705. That figure is the rounded market value total reported on the Form 13F summary page for the holdings included in this filing.

Does this Form 13F disclose transaction activity or trades?

No — it reports positions, not detailed trades. Form 13F lists securities held at quarter end; it does not provide trade timestamps or buy/sell details for each position in this summary excerpt.